Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types

被引:75
作者
Boerger, AL [1 ]
Snitkovsky, S [1 ]
Young, JAT [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.96.17.9867
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Successful targeting methods represent a major hurdle to the use of retroviral vectors in cell-specific gene-delivery applications. We recently described an approach for retroviral targeting with a retroviral receptor-ligand bridge protein that was bound to the cognate cell-surface ligand receptors before viral challenge. We now report a significant improvement made to this viral targeting method by using a related bridge protein, designated TVB-EGF, comprised of the extracellular domain of the TVB receptor for subgroup B avian leukosis virus fused to epidermal growth factor (EGF), The most important activity of TVB-EGF was that it allowed specific viral entry when preloaded onto virions, Furthermore, virions preloaded with TVB-EGF were thermostable and could be produced directly from viruspackaging cells. These data suggest an approach for targeting retroviral vectors to specific cell types by using virions preloaded with a retroviral receptor-ligand bridge protein and indicate that these types of bridge proteins may be useful reagents for studying the normal mechanism of retroviral entry.
引用
收藏
页码:9867 / 9872
页数:6
相关论文
共 35 条
[11]   LIGAND-INDUCED ENDOCYTOSIS OF THE EGF RECEPTOR IS BLOCKED BY MUTATIONAL INACTIVATION AND BY MICROINJECTION OF ANTI-PHOSPHOTYROSINE ANTIBODIES [J].
GLENNEY, JR ;
CHEN, WS ;
LAZAR, CS ;
WALTON, GM ;
ZOKAS, LM ;
ROSENFELD, MG ;
GILL, GN .
CELL, 1988, 52 (05) :675-684
[12]  
Gullick WJ, 1998, BIOCHEM SOC SYMP, P193
[13]   LIGAND-DIRECTED RETROVIRAL TARGETING OF HUMAN BREAST-CANCER CELLS [J].
HAN, XL ;
KASAHARA, N ;
KAN, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9747-9751
[14]   Activation of a retroviral membrane fusion protein: Soluble receptor-induced liposome binding of the ALSV envelope glycoprotein [J].
Hernandez, LD ;
Peters, RJ ;
Delos, SE ;
Young, JAT ;
Agard, DA ;
White, JM .
JOURNAL OF CELL BIOLOGY, 1997, 139 (06) :1455-1464
[15]   GENE-THERAPY OF METASTATIC CANCER BY IN-VIVO RETROVIRAL GENE TARGETING [J].
HURFORD, RK ;
DRANOFF, G ;
MULLIGAN, RC ;
TEPPER, RI .
NATURE GENETICS, 1995, 10 (04) :430-435
[16]   Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies [J].
Jiang, A ;
Chu, THT ;
Nocken, F ;
Cichutek, K ;
Dornburg, R .
JOURNAL OF VIROLOGY, 1998, 72 (12) :10148-10156
[17]   TISSUE-SPECIFIC TARGETING OF RETROVIRAL VECTORS THROUGH LIGAND-RECEPTOR INTERACTIONS [J].
KASAHARA, N ;
DOZY, AM ;
KAN, YW .
SCIENCE, 1994, 266 (5189) :1373-1376
[18]   PACKAGING SYSTEM FOR RAPID PRODUCTION OF MURINE LEUKEMIA-VIRUS VECTORS WITH VARIABLE TROPISM [J].
LANDAU, NR ;
LITTMAN, DR .
JOURNAL OF VIROLOGY, 1992, 66 (08) :5110-5113
[19]   Targeted infection of human cells via major histocompatibility complex class I molecules by moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins [J].
Marin, M ;
Noel, D ;
ValsesiaWittman, S ;
Brockly, F ;
EtienneJulan, M ;
Russell, S ;
Cosset, FL ;
Piechaczyk, M .
JOURNAL OF VIROLOGY, 1996, 70 (05) :2957-2962
[20]   TARGETED INFECTION OF A RETROVIRUS BEARING A CD4-ENV CHIMERA INTO HUMAN-CELLS EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
MATANO, T ;
ODAWARA, T ;
IWAMOTO, A ;
YOSHIKURA, H .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :3165-3169